Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00969878 · ClinicalTrials.gov registry record · Phase 2
Multisite Controlled Trial of Cocaine Vaccine
A Phase 2 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT00969878 is a Phase 2 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 300 participants.
The verdict
NCT00969878, a Phase 2 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD).
Interventions
- OTHER Placebo Injection
- DRUG TA-CD Vaccination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00969878
The ClinicalTrials.gov registry entry for NCT00969878 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Injection is the first listed.
NCT00969878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00969878 about?
NCT00969878 is a clinical study titled "Multisite Controlled Trial of Cocaine Vaccine". The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD).
What is the current status of trial NCT00969878?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2010-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00969878?
The interventions under investigation include: Placebo Injection (OTHER), TA-CD Vaccination (DRUG).
Who is sponsoring clinical trial NCT00969878?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.